Refocusing the RU-486 debate at Yale
On Monday, the Yale community was shocked or delighted to learn Yale will be offering the morning-after pill RU-486 to students and staff under its standard health plan. The vitally important abortion debate is now back where it belongs, in the hands of those who will undoubtedly be world leaders a few short years from now.
Unfortunately, the debate is far from focused on the important issues. The administration is clashing over technical issues. The pro-life group is complaining their tuition dollars are funding something evil. The administration's talking points, obviously...
Sorry, but comments are disabled for this article.